MX2010004292A - Producto de dispersion solida que contiene un compuesto a base de n-aril urea. - Google Patents
Producto de dispersion solida que contiene un compuesto a base de n-aril urea.Info
- Publication number
- MX2010004292A MX2010004292A MX2010004292A MX2010004292A MX2010004292A MX 2010004292 A MX2010004292 A MX 2010004292A MX 2010004292 A MX2010004292 A MX 2010004292A MX 2010004292 A MX2010004292 A MX 2010004292A MX 2010004292 A MX2010004292 A MX 2010004292A
- Authority
- MX
- Mexico
- Prior art keywords
- solid dispersion
- dispersion product
- based compound
- product containing
- aryl urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
Un producto que comprende al menos un agente farmacéuticamente activo a base de N-aril urea o un agente de estructura relacionada que es obtenido mediante a) la preparación de una mezcla líquida que contiene el al menos un agente activo, el al menos un agente formador de matriz aceptable para uso farmacéutico, el al menos un agente tensoactivo aceptable para uso farmacéutico y el al menos un solvente, y b) la eliminación del o de los solventes de la mezcla líquida para obtener el producto de dispersión sólida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961307P | 2007-10-19 | 2007-10-19 | |
PCT/EP2008/064073 WO2009050289A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product containing n-aryl urea-based compound |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004292A true MX2010004292A (es) | 2010-08-02 |
Family
ID=40089072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004292A MX2010004292A (es) | 2007-10-19 | 2008-10-17 | Producto de dispersion solida que contiene un compuesto a base de n-aril urea. |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090143423A1 (es) |
EP (1) | EP2197426A2 (es) |
JP (1) | JP2011500647A (es) |
KR (1) | KR20100090689A (es) |
CN (1) | CN101827585A (es) |
AR (1) | AR068916A1 (es) |
AU (1) | AU2008313620A1 (es) |
BR (1) | BRPI0818339A2 (es) |
CA (1) | CA2699335A1 (es) |
CL (1) | CL2008003092A1 (es) |
CO (1) | CO6270303A2 (es) |
CR (1) | CR11441A (es) |
DO (1) | DOP2010000114A (es) |
EC (1) | ECSP10010184A (es) |
GT (1) | GT201000095A (es) |
MX (1) | MX2010004292A (es) |
PE (1) | PE20091041A1 (es) |
RU (1) | RU2010119924A (es) |
TW (1) | TW200922549A (es) |
UA (1) | UA100866C2 (es) |
UY (1) | UY31406A1 (es) |
WO (1) | WO2009050289A2 (es) |
ZA (1) | ZA201002130B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010045402A1 (en) * | 2008-10-17 | 2010-04-22 | Abbott Laboratories | Trpv1 antagonists |
AR073631A1 (es) * | 2008-10-17 | 2010-11-17 | Abbott Lab | Antagonistas del receptor transitorio potencial de vanilloides 1 ( trpv1) utiles para tratar inflamacion y dolor |
US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
WO2011032860A1 (de) * | 2009-09-18 | 2011-03-24 | Basf Se | Verfahren zur herstellung von zubereitungen von in wasser schwerlöslichen substanzen |
EP2654731B1 (en) * | 2010-12-23 | 2016-07-27 | AbbVie Deutschland GmbH & Co. KG | Solid retard formulations based on solid dispersions |
CN103391770A (zh) | 2011-01-10 | 2013-11-13 | 细胞基因公司 | 环丙烷羧酸{2-[(1s)-1-(3-乙氧基-4-甲氧基-苯基)-2-甲烷磺酰基-乙基]-3-氧代-2,3-二氢-1h-异吲哚-4-基}-酰胺的口服剂型 |
EP2907505A3 (en) * | 2011-12-29 | 2015-12-30 | Abbvie Inc. | Solid compositions comprising an HCV inhibitor |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
PL2950786T3 (pl) | 2013-01-31 | 2020-05-18 | Gilead Pharmasset Llc | Formulacja skojarzona dwóch związków przeciwwirusowych |
EA032322B1 (ru) | 2013-03-15 | 2019-05-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Твердая пероральная дозированная композиция ингибитора hcv в аморфном состоянии |
US10046151B2 (en) | 2013-07-03 | 2018-08-14 | Lts Lohmann Therapie-Systeme, Ag | Transdermal therapeutic system with electronic component |
PL3038601T3 (pl) | 2013-08-27 | 2020-08-24 | Gilead Pharmasset Llc | Formulacja złożona dwóch związków przeciwwirusowych |
CN106456567A (zh) | 2014-05-20 | 2017-02-22 | Lts勒曼治疗系统股份公司 | 在经皮递送系统中调节活性剂释放的方法 |
CN106456566B (zh) * | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
CA2948221C (en) | 2014-05-20 | 2022-11-22 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
CA3039767C (en) * | 2015-12-22 | 2023-11-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia |
CA3117563A1 (en) * | 2018-10-30 | 2020-05-07 | Peloton Therapeutics, Inc. | Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof |
WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
JP6830569B1 (ja) | 2019-08-23 | 2021-02-17 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362878A (en) * | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
EP0642498A1 (en) * | 1992-05-28 | 1995-03-15 | Pfizer Inc. | NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT) |
CA2302735A1 (en) * | 1998-07-14 | 2000-01-27 | Em Industries, Inc. | Microdisperse drug delivery systems |
US7015233B2 (en) * | 2003-06-12 | 2006-03-21 | Abbott Laboratories | Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
BRPI0511900A (pt) * | 2004-06-08 | 2008-01-22 | Vertex Pharma | composições farmacêuticas |
JP5128948B2 (ja) * | 2004-08-27 | 2013-01-23 | ニッポネックス インコーポレイテッド | 癌の治療のための新規な薬剤組成物 |
MX2007012947A (es) * | 2005-04-18 | 2008-04-09 | Rubicon Res Pvt Ltd | Composiciones biomejoradas. |
KR100715355B1 (ko) * | 2005-09-30 | 2007-05-07 | 주식회사유한양행 | 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법 |
US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
US7745448B2 (en) * | 2005-12-28 | 2010-06-29 | Abbott Laboratories Inc. | Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate |
JP5773560B2 (ja) * | 2006-02-09 | 2015-09-02 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Cetp阻害剤のポリマー製剤 |
-
2008
- 2008-10-17 CL CL2008003092A patent/CL2008003092A1/es unknown
- 2008-10-17 AR ARP080104542A patent/AR068916A1/es not_active Application Discontinuation
- 2008-10-17 AU AU2008313620A patent/AU2008313620A1/en not_active Abandoned
- 2008-10-17 MX MX2010004292A patent/MX2010004292A/es not_active Application Discontinuation
- 2008-10-17 PE PE2008001785A patent/PE20091041A1/es not_active Application Discontinuation
- 2008-10-17 CN CN200880112161A patent/CN101827585A/zh active Pending
- 2008-10-17 US US12/253,499 patent/US20090143423A1/en not_active Abandoned
- 2008-10-17 CA CA2699335A patent/CA2699335A1/en not_active Abandoned
- 2008-10-17 EP EP08840773A patent/EP2197426A2/en not_active Withdrawn
- 2008-10-17 TW TW097140229A patent/TW200922549A/zh unknown
- 2008-10-17 WO PCT/EP2008/064073 patent/WO2009050289A2/en active Application Filing
- 2008-10-17 UA UAA201006030A patent/UA100866C2/ru unknown
- 2008-10-17 KR KR1020107010874A patent/KR20100090689A/ko not_active Application Discontinuation
- 2008-10-17 JP JP2010529406A patent/JP2011500647A/ja active Pending
- 2008-10-17 BR BRPI0818339 patent/BRPI0818339A2/pt not_active IP Right Cessation
- 2008-10-17 UY UY31406A patent/UY31406A1/es not_active Application Discontinuation
- 2008-10-17 RU RU2010119924/15A patent/RU2010119924A/ru not_active Application Discontinuation
-
2010
- 2010-03-25 ZA ZA2010/02130A patent/ZA201002130B/en unknown
- 2010-04-15 GT GT201000095A patent/GT201000095A/es unknown
- 2010-04-16 DO DO2010000114A patent/DOP2010000114A/es unknown
- 2010-04-27 CO CO10049270A patent/CO6270303A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010184A patent/ECSP10010184A/es unknown
- 2010-05-19 CR CR11441A patent/CR11441A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY31406A1 (es) | 2009-05-29 |
CL2008003092A1 (es) | 2009-11-27 |
JP2011500647A (ja) | 2011-01-06 |
CN101827585A (zh) | 2010-09-08 |
RU2010119924A (ru) | 2011-11-27 |
BRPI0818339A2 (pt) | 2015-04-22 |
ZA201002130B (en) | 2011-11-30 |
PE20091041A1 (es) | 2009-08-22 |
DOP2010000114A (es) | 2010-05-15 |
CR11441A (es) | 2010-10-25 |
CO6270303A2 (es) | 2011-04-20 |
ECSP10010184A (es) | 2010-06-29 |
GT201000095A (es) | 2012-04-03 |
KR20100090689A (ko) | 2010-08-16 |
UA100866C2 (ru) | 2013-02-11 |
CA2699335A1 (en) | 2009-04-23 |
AR068916A1 (es) | 2009-12-16 |
TW200922549A (en) | 2009-06-01 |
WO2009050289A3 (en) | 2010-03-25 |
WO2009050289A2 (en) | 2009-04-23 |
US20090143423A1 (en) | 2009-06-04 |
AU2008313620A1 (en) | 2009-04-23 |
EP2197426A2 (en) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004292A (es) | Producto de dispersion solida que contiene un compuesto a base de n-aril urea. | |
MX2010004291A (es) | Producto de dispersion solida de farmacos basados en n-aril urea. | |
WO2010015567A3 (en) | Controlled release formulations using intelligent polymers | |
AR055561A1 (es) | Comprimidos con dispersion mejorada de la sustancia farmacologica | |
WO2009082152A3 (en) | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient | |
WO2007125103A3 (en) | Benzamide glucokinase activators | |
WO2007086078A3 (en) | Novel pharmaceutical compositions and process of preparation thereof | |
WO2009135179A3 (en) | The use of solid carrier particles to improve the processability of a pharmaceutical agent | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
PL2046292T3 (pl) | Preparaty eterów benzymidazolilo-pirydylowych | |
WO2008073138A3 (en) | Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors | |
WO2008103847A3 (en) | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | |
WO2010017433A3 (en) | Use of sucralose as a granulating agent | |
EP2011544A3 (en) | Structured Depilatory Compositions | |
WO2008098978A3 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
WO2009060952A1 (ja) | 新規製剤 | |
WO2011103610A3 (de) | Pflanzenschutzmittel | |
MX2015005762A (es) | Producto de comicronizacion que comprende acetato de ulipristal. | |
WO2007065625A3 (en) | Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations | |
WO2009097973A3 (de) | Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel | |
WO2008022745A8 (de) | Formulierungen zur kontrollierten freisetzung agrochemischer wirkstoffe | |
WO2010058104A3 (fr) | Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation | |
WO2007143506A3 (en) | Substituted benzimidazole thiophene benzyl ether compounds | |
WO2010061219A3 (en) | Polymorphs | |
WO2009022066A3 (fr) | Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |